AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Ouster, I think you have to believe lidar can become a core layer of smart infrastructure and software driven traffic intelligence, and that the company can translate deployments into improving margins while still unprofitable. Utah’s choice to expand BlueCity with OS1 Max Rev8 reinforces the near term catalyst around Intelligent Transportation Systems adoption, but it does not remove the key risks of competition, gross margin variability, and ongoing losses.
The most relevant recent announcement here is Ouster’s June launch of BlueCity powered by Rev8, which introduced native color lidar, 360° detection, and at edge analytics. Utah’s expanded roll out looks like an early, real world test of that product story, connecting the ITS growth catalyst to Ouster’s broader push toward software attached, higher value deployments that could matter for revenue quality more than raw sensor volumes.
Yet while Utah’s expansion hints at progress, the ongoing risk that quarterly results swing with shipment timing and cost volatility is something investors should be very aware of as...
Read the full narrative on Ouster (it's free!)
Ouster's narrative projects $484.7 million revenue and $16.9 million earnings by 2029.
Uncover how Ouster's forecasts yield a $57.83 fair value, a 51% upside to its current price.
Compared with the baseline, the most optimistic analysts were already assuming about US$449.4 million of revenue by 2029 and see Utah’s win as potentially reinforcing, not resolving, questions about whether lidar can fend off cheaper vision systems and justify that faster adoption curve.
Explore 8 other fair value estimates on Ouster - why the stock might be worth less than half the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com